RxDoctor Payments Data

Son Vu, MD

Family Medicine · Wyomissing, PANPI 1831199975

Payments from drug & device makers

$169in general payments, 2019–2025

Across 11 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$35
  • Amgen$29
  • Supernus Pharmaceuticals, Inc.$23
  • Astellas Pharma US Inc$16
  • AstraZeneca$14
  • Boehringer Ingelheim$13
  • plus $37 from 3 others

What the payments were for

  • Food & beverage$169100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$169 in reported general payments places this provider in the 40th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$119,727
Medicare patients
301
Services billed
1,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban80$95,958
OzempicSemaglutide56$82,597
JardianceEmpagliflozin68$80,282
JanuviaSitagliptin Phosphate47$46,368
TrulicityDulaglutide25$30,962
XareltoRivaroxaban15$23,681
TradjentaLinagliptin23$22,890
FarxigaDapagliflozin Propanediol14$17,998
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,412
InvokanaCanagliflozin12$10,186
Atorvastatin Calcium702$6,628
Arnuity ElliptaFluticasone Furoate20$5,501
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$3,869
Albuterol Sulfate HfaAlbuterol Sulfate82$3,234
Amlodipine Besylate538$3,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$13$103,17291 claims
PfizerEliquis$12$95,95880 claims
Novo NordiskOzempic$35$82,59756 claims
AstraZenecaFarxiga$14$17,99814 claims
GSKTrelegy Ellipta, Arnuity Ellipta$12$17,91240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Wyomissing

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →